643 related articles for article (PubMed ID: 26568586)
21. Long-Term Clinical Outcomes in a Cohort of Adults With Childhood-Onset Systemic Lupus Erythematosus.
Groot N; Shaikhani D; Teng YKO; de Leeuw K; Bijl M; Dolhain RJEM; Zirkzee E; Fritsch-Stork R; Bultink IEM; Kamphuis S
Arthritis Rheumatol; 2019 Feb; 71(2):290-301. PubMed ID: 30152151
[TBL] [Abstract][Full Text] [Related]
22. Autoimmune hepatitis in 847 childhood-onset systemic lupus erythematosus population: a multicentric cohort study.
Balbi VA; Montenegro B; Pitta AC; Schmidt AR; Farhat SC; Coelho LP; Ferreira JCO; Pereira RMR; Terreri MT; Saad-Magalhães C; Aikawa NE; Sakamoto AP; Kozu K; Campos LM; Sallum AM; Ferriani VP; Piotto DP; Bonfá E; Silva CA
Adv Rheumatol; 2018 Dec; 58(1):43. PubMed ID: 30657090
[TBL] [Abstract][Full Text] [Related]
23. Impact of follow-up adherence on disease activity in childhood-onset systemic lupus erythematosus (cSLE).
Nelson MC; Mosley C; Villacis-Nunez DS; Rouster-Stevens K; Thakral A
Lupus; 2023 May; 32(6):799-803. PubMed ID: 37125694
[TBL] [Abstract][Full Text] [Related]
24. Disease presentation of 1312 childhood-onset systemic lupus erythematosus: influence of ethnicity.
Fiorot FJ; Islabão AG; Pereira RM; Terreri MT; Saad-Magalhães C; Novak GV; Molinari BC; Sakamoto AP; Aikawa NE; Campos LM; Peracchi OA; Appenzeller S; Ferriani VP; Silva MF; Fonseca AR; Sztajnbok FR; Paim LB; Fraga MM; Okuda EM; Bica BE; Sena EG; Moraes AJ; Rolim AM; Spelling PF; Scheibel IM; Cavalcanti AS; Matos EN; Robazzi TC; Guimarães LJ; Santos FP; Ramos VC; Carneiro-Sampaio M; Bonfá E; Silva CA;
Clin Rheumatol; 2019 Oct; 38(10):2857-2863. PubMed ID: 31209708
[TBL] [Abstract][Full Text] [Related]
25. Clinical features and long-term outcomes of systemic lupus erythematosus: comparative data of childhood, adult and late-onset disease in a national register.
Sousa S; Gonçalves MJ; Inês LS; Eugénio G; Jesus D; Fernandes S; Terroso G; Romão VC; Cerqueira M; Raposo A; Couto M; Nero P; Sequeira G; Nóvoa T; Melo Gomes JA; da Silva JC; Costa L; Macieira C; Silva C; Silva JA; Canhão H; Santos MJ
Rheumatol Int; 2016 Jul; 36(7):955-60. PubMed ID: 26979603
[TBL] [Abstract][Full Text] [Related]
26. Late-onset systemic lupus erythematosus: characteristics and outcome in comparison to juvenile- and adult-onset patients-a multicenter retrospective cohort.
Medhat BM; Behiry ME; Sobhy N; Farag Y; Marzouk H; Mostafa N; Khalifa I; Elkhalifa M; Eissa BM; Hassan EHE
Clin Rheumatol; 2020 Feb; 39(2):435-442. PubMed ID: 31758421
[TBL] [Abstract][Full Text] [Related]
27. High disease activity: an independent factor for reduced immunogenicity of the pandemic influenza a vaccine in patients with juvenile systemic lupus erythematosus.
Campos LM; Silva CA; Aikawa NE; Jesus AA; Moraes JC; Miraglia J; Ishida MA; Bueno C; Pereira RM; Bonfa E
Arthritis Care Res (Hoboken); 2013 Jul; 65(7):1121-7. PubMed ID: 23818263
[TBL] [Abstract][Full Text] [Related]
28. Pentraxin-3 levels are associated with vasculitis and disease activity in childhood-onset systemic lupus erythematosus.
Sahin S; Adrovic A; Barut K; Durmus S; Gelisgen R; Uzun H; Kasapcopur O
Lupus; 2017 Sep; 26(10):1089-1094. PubMed ID: 28420068
[TBL] [Abstract][Full Text] [Related]
29. Invasive fungal infections in patients with systemic lupus erythematosus.
Martínez-Martínez MU; Herrera-Van Oostdam D; Román-Acosta S; Magaña-Aquino M; Baranda-Cándido L; Abud-Mendoza C
J Rheumatol; 2012 Sep; 39(9):1814-8. PubMed ID: 22707608
[TBL] [Abstract][Full Text] [Related]
30. Invasive fungal infections in pediatric bone marrow transplant recipients: single center experience of 10 years.
Hovi L; Saarinen-Pihkala UM; Vettenranta K; Saxen H
Bone Marrow Transplant; 2000 Nov; 26(9):999-1004. PubMed ID: 11100280
[TBL] [Abstract][Full Text] [Related]
31. Prevalence and features of metabolic syndrome in childhood-onset systemic lupus erythematosus.
Sinicato NA; Postal M; de Oliveira Peliçari K; Rittner L; Marini R; Appenzeller S
Clin Rheumatol; 2017 Jul; 36(7):1527-1535. PubMed ID: 28424906
[TBL] [Abstract][Full Text] [Related]
32. Pancreatitis Subtypes Survey in 852 Childhood-Onset Systemic Lupus Erythematosus Patients.
Marques VL; Gormezano NW; Bonfá E; Aikawa NE; Terreri MT; Pereira RM; Magalhães CS; Guariento A; Appenzeller S; Ferriani VP; Barbosa CM; Ramos VC; Lotufo S; Silva CA
J Pediatr Gastroenterol Nutr; 2016 Feb; 62(2):328-34. PubMed ID: 26418213
[TBL] [Abstract][Full Text] [Related]
33. Late-onset systemic lupus erythematosus in Latin Americans: a distinct subgroup?
Catoggio LJ; Soriano ER; Imamura PM; Wojdyla D; Jacobelli S; Massardo L; Chacón Díaz R; Guibert-Toledano M; Alvarellos A; Saurit V; Manni JA; Pascual-Ramos V; Silva de Sauza AW; Bonfa E; Tavares Brenol JC; Ramirez LA; Barile-Fabris LA; De La Torre IG; Alarcón GS; Pons-Estel BA;
Lupus; 2015 Jul; 24(8):788-95. PubMed ID: 25504653
[TBL] [Abstract][Full Text] [Related]
34. A retrospective study of catastrophic invasive fungal infections in patients with systemic lupus erythematosus from southern Taiwan.
Weng CT; Lee NY; Liu MF; Weng MY; Wu AB; Chang TW; Lin TS; Wang JY; Chang HY; Wang CR
Lupus; 2010 Sep; 19(10):1204-9. PubMed ID: 20515999
[TBL] [Abstract][Full Text] [Related]
35. Cytokine profile in childhood-onset systemic lupus erythematosus: a cross-sectional and longitudinal study.
Cavalcanti A; Santos R; Mesquita Z; Duarte AL; Lucena-Silva N
Braz J Med Biol Res; 2017 Apr; 50(4):e5738. PubMed ID: 28380214
[TBL] [Abstract][Full Text] [Related]
36. Invasive fungal infections in patients with systemic lupus erythematosus: experience from affiliated hospitals of Catholic University of Korea.
Kim HJ; Park YJ; Kim WU; Park SH; Cho CS
Lupus; 2009 Jun; 18(7):661-6. PubMed ID: 19433470
[TBL] [Abstract][Full Text] [Related]
37. Assessment of clinical manifestations, disease activity and organ damage in 996 Korean patients with systemic lupus erythematosus: comparison with other Asian populations.
Joo YB; Bae SC
Int J Rheum Dis; 2015 Feb; 18(2):117-28. PubMed ID: 25524656
[TBL] [Abstract][Full Text] [Related]
38. Chronic arthritis in systemic lupus erythematosus: distinct features in 336 paediatric and 1830 adult patients.
Gormezano NW; Silva CA; Aikawa NE; Barros DL; da Silva MA; Otsuzi CI; Kozu K; Seguro LP; Pereira RM; Bonfá E
Clin Rheumatol; 2016 Jan; 35(1):227-31. PubMed ID: 26615611
[TBL] [Abstract][Full Text] [Related]
39. Anti-ribosomal P antibody: a multicenter study in childhood-onset systemic lupus erythematosus patients.
Valões CC; Molinari BC; Pitta AC; Gormezano NW; Farhat SC; Kozu K; Sallum AM; Appenzeller S; Sakamoto AP; Terreri MT; Pereira RM; Magalhães CS; Ferreira JC; Barbosa CM; Gomes FH; Bonfá E; Silva CA;
Lupus; 2017 Apr; 26(5):484-489. PubMed ID: 28394238
[TBL] [Abstract][Full Text] [Related]
40. Treatment of invasive fungal infections in high risk hematological patients. The outcome with liposomal amphotericin B is not negatively affected by prior administration of mold-active azoles.
De la Serna J; Jarque I; López-Jiménez J; Fernández-Navarro JM; Gómez V; Jurado M; Pascual A; Serrano J; Romero M; Vallejo C
Rev Esp Quimioter; 2013 Mar; 26(1):64-9. PubMed ID: 23546466
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
